Delivery Order SPE2DE24D0021-SPE2D625F9TM6
- Not listed
- Fisher Scientific Company L.L.C. received a delivery order award on July 31, 2025, from the Department of Defense's Medical Supply Chain for reagent toxicology CEDIA buprenorphine supplies, with a ceiling value of $8,323.12. This fixed-price delivery order with economic price adjustment provisions is structured as a child contract, indicating it derives from a larger parent agreement—specifically Fisher Scientific's Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans...
- This federal contract award, valued at $2,649.60, was issued by the Department of Defense to Fisher Scientific Company L.L.C., a for-profit limited liability company that is a major supplier of scientific products, equipment, and services to federal government agencies. The contract is for the delivery of reagent toxicology methadone metabolite products, with a completion date of June 12, 2025. Fisher Scientific has a long history of supporting federal agencies through prime contract awards,...
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,949.88 on August 4, 2025, under a fixed-price contract with economic price adjustment provisions. The contract, with an ultimate completion date of August 18, 2025, involves the provision of panel toxicology testing and qualification training for toxicology testing related to nine drugs. Performance will take place in Pittsburgh, Pennsylvania. This delivery order is issued under a larger Blanket Purchase Agreement with...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $4,962.50 from the Medical Supply Chain, a defense-focused federal agency, for serum toxicology testing reagents and TRIAG materials. The order, issued on August 20, 2025, with an ultimate completion date of September 4, 2025, will be performed in Pittsburgh, Pennsylvania. This delivery order was awarded without a set-aside designation through open competition, reflecting Fisher Scientific's established capability...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $8,266.56 for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, on July 24, 2025. The contract carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by July 31, 2025. This is an uncompensated delivery order with no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 by the Defense Medical Supply Chain federal agency for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack. This fixed-price delivery order with economic price adjustment was awarded on July 18, 2025, with an ultimate completion date of July 25, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract, indicating it falls under a larger...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory supplies and scientific equipment, was awarded a delivery order valued at $4,430.32 by the Department of Defense's Medical Supply Chain agency on August 8, 2025. This fixed-price delivery order with economic price adjustment clause is classified as a child contract, indicating it derives from a larger procurement vehicle. The order is scheduled for completion by August 22, 2025, with performance taking place at Fisher...
- Fisher Scientific Company L.L.C. was awarded a $3,099.96 fixed-price delivery order with economic price adjustment on August 11, 2025, to supply PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits at 25 per package. The contract, which is a child order under a larger vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 25, 2025. No set-aside designation was used in this award. The funding source is identified as the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $12,291.24 on August 12, 2025, for the procurement of VT Reagent DHDL SLD 300/Pack laboratory supplies. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 15, 2025. The award was made without set-aside designation through open competition, reflecting Fisher Scientific's established competitive standing as a major federal supplier....
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F9TM6Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order on July 31, 2025, for the procurement of reagent toxicology methadone metabolite supplies, valued at $1,177.60, with an ultimate completion date of August 7, 2025. This fixed-price delivery order with economic price adjustment represents a child contract under a larger federal vehicle and will be performed in Pittsburgh, PA. The award was made by the Medical Supply Chain division of the Department of Defense without a set-aside designation, reflecting Fisher Scientific's competitive capabilities in the federal marketplace. This delivery order falls under Fisher Scientific's broader Blanket Purchase Agreement with the Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), a single-award BPA valued at $1.65 million and running through September 30, 2030. The BPA is structured to supply specialized toxicology and drugs of abuse reagents to support laboratory testing across 11 VISN 1 locations in the Northeastern United States. The methadone metabolite reagents being procured under this delivery order support critical drug testing and toxicology operations essential to the department's healthcare and clinical laboratory missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/31/25 |